Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04279444 · ClinicalTrials.gov registry record · NA
Effects of BKR-017 on Insulin Resistance in Type 2 Diabetes Patients
A NA study, sponsored by BioKier.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT04279444 is a NA study that has completed, run by BioKier. The registered enrollment target is 14 participants.
The verdict
NCT04279444, a NA study, has completed, sponsored by BioKier.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of BKR-017 on insulin resistance in type 2 diabetes (T2D) subjects during 28 days of active test product administration.
Interventions
- DIETARY_SUPPLEMENT BKR-017
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2020-06-16 |
| Est. Completion | 2020-11-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04279444
The ClinicalTrials.gov registry entry for NCT04279444 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BioKier, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BKR-017 is the first listed.
NCT04279444 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04279444 about?
NCT04279444 is a clinical study titled "Effects of BKR-017 on Insulin Resistance in Type 2 Diabetes Patients". The purpose of this study is to evaluate the effect of BKR-017 on insulin resistance in type 2 diabetes (T2D) subjects during 28 days of active test product administration.
What is the current status of trial NCT04279444?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2020-06-16. Estimated completion is 2020-11-15.
What interventions are being tested in trial NCT04279444?
The interventions under investigation include: BKR-017 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04279444?
This trial is sponsored by BioKier, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.